Growth/Biotech & Pharma

Deploy a Chief Marketing Officer for your biotech or pharma company.

Bypass bloated consulting firms. Secure a US-based, Ivy League-educated CMO to navigate crossover or series c fundraise — entirely remotely, deployed in 48 hours.

48 hr
Avg. Deployment
100%
US-Based · Ivy League
14 day
No-Cause Cancellation
The Mandate

What Biotech & Pharma CEOs hire CMOs to solve.

  • 01Capital efficiency between trial milestones
  • 02Clinical, regulatory and commercial coordination
  • 03BD, licensing and pharma-partner negotiations
  • 04GxP, quality and supply chain readiness
Common Engagements

Where this CMO plugs in across Biotech & Pharma.

Crossover or Series C fundraise

Rebrand or category redefinition

BD and licensing program

Scaling paid acquisition past the first ceiling

Commercial launch preparation

Establishing a content and SEO moat from scratch

Quality and compliance overhaul

Product launch or major announcement orchestration

Ready to DeployYour operator can be on the inside by Thursday.Choose a Tier
Deliverables

What lands in week one.

  • Brand positioning brief and messaging architecture
  • Channel investment plan with payback assumptions
  • Editorial and content calendar (rolling 90 days)
  • Marketing dashboard tied to CAC, LTV, and pipeline contribution
KPIs Owned

The scoreboard they answer to.

  • ·Blended CAC and LTV:CAC ratio
  • ·Marketing-sourced pipeline and revenue
  • ·Organic traffic and branded search lift
  • ·Conversion rate by channel and stage

A Crimson Bench CMO gives marketing executive discipline: category narrative, acquisition architecture, channel accountability, launch orchestration, and a brand system that supports revenue instead of decorating it.

Still Evaluating?

Start with a $1,500 Executive Diagnostic — 2 hours, 3-page roadmap, refundable.

Live Bench